← back to search

Gordon J. Chelune

University of Utah · US
Area of research
Psychiatry and Mental health · Cognitive Neuroscience
Research interest
Research interests include Dementia and Cognitive Impairment Research, Epilepsy research and treatment, Neurobiology of Language and Bilingualism, and Cognitive Abilities and Testing.
h-index
57
citations
12,384
works
207
NIH funding
primary concept
email

Recent publications

Long-Term Effect of Intensive vs Standard Blood Pressure Control on Mild Cognitive Impairment and Probable Dementia in SPRINT
Neurology 2025cited by 19position: middledoi
Robust demographically-adjusted normative data for the Montreal Cognitive Assessment (MoCA): Results from the systolic blood pressure intervention trial
The Clinical Neuropsychologist 2021cited by 31position: middledoi
Effect of intensive blood pressure control on subtypes of mild cognitive impairment and risk of progression from <scp>SPRINT</scp> study
Journal of the American Geriatrics Society 2021cited by 15position: middledoi
Effects of intensive versus standard blood pressure control on domain-specific cognitive function: a substudy of the SPRINT randomised controlled trial
The Lancet Neurology 2020cited by 81position: middledoi
Consensus Parameter: Research Methodologies to Evaluate Neurodevelopmental Effects of Pubertal Suppression in Transgender Youth
Transgender Health 2020cited by 43position: middledoi
Kidney Disease, Intensive Hypertension Treatment, and Risk for Dementia and Mild Cognitive Impairment: The Systolic Blood Pressure Intervention Trial
Journal of the American Society of Nephrology 2020cited by 40position: middledoi
Effect of Intensive vs Standard Blood Pressure Control on Probable Dementia
JAMA 2019cited by 1,186position: middledoi
Association of Intensive vs Standard Blood Pressure Control With Cerebral White Matter Lesions
JAMA 2019cited by 407position: middledoi
Cognitive Function and Kidney Disease: Baseline Data From the Systolic Blood Pressure Intervention Trial (SPRINT)
American Journal of Kidney Diseases 2017cited by 78position: middledoi
Chronic kidney disease, cerebral blood flow, and white matter volume in hypertensive adults
Neurology 2016cited by 65position: middledoi
Antidepressant and Neurocognitive Effects of Isoflurane Anesthesia versus Electroconvulsive Therapy in Refractory Depression
PLoS ONE 2013cited by 78position: middledoi
Confronting Patients About Insufficient Effort: The Impact on Subsequent Symptom Validity and Memory Performance
The Clinical Neuropsychologist 2012cited by 39position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Sarah A. Gaussoin · Landscape Research Group5 papers (2017–2025)Jeff D. Williamson · University Memory and Aging Center5 papers (2017–2025)Nicholas M. Pajewski · Wake Forest University4 papers (2020–2025)Alan J. Lerner · Case Western Reserve University4 papers (2017–2025)Stephen R. Rapp · Wake Forest University4 papers (2020–2025)Bonnie C. Sachs · New York University3 papers (2021–2025)Virginia G. Wadley · University of Alabama at Birmingham3 papers (2021–2025)Mark A. Supiano · University of Utah3 papers (2020–2025)William E. Haley · Wake Forest University2 papers (2017–2020)David M. Reboussin · Wake Forest University2 papers (2021–2025)Suzanne Oparil · University of Alabama at Birmingham2 papers (2017–2020)Maryjo Cleveland · Wake Forest University2 papers (2021–2025)Daniel E. Weiner · Tufts Medical Center2 papers (2017–2020)Kaycee M. Sink · Columbia University2 papers (2021–2021)Manjula Kurella Tamura · Palo Alto University2 papers (2017–2020)Laura H. Coker · Sprint (United States)2 papers (2017–2021)Clinton B. Wright · National Institute of Neurological Disorders and Stroke2 papers (2017–2021)Tanya R. Gure · The Ohio State University2 papers (2020–2021)Linda O. Nichols · University of Warwick2 papers (2021–2021)Paula Ogrocki · Case Western Reserve University2 papers (2021–2025)